- Analytical Procedures for Viral Vectored Vaccine Quality (posted 29-Apr-2022)
- Deferred Proposal: General Notices and Requirements, 5.60.40 Impurities that are Unusually Toxic and/or Mutagenic (posted 30–Sep–2020)
- First Draft of Roadmap for Addressing Element-Specific Chapters and Tests in Excipient Monographs (posted 05–Aug–2020)
- Modification to USP–NF 2021, Issue 2 Revisions, Deferrals, and Cancellations Lists (posted 29–Jan–2021)
- New General Chapter <1220> Analytical Procedure Life Cycle (posted 24–Sep–2021)
- New Inhalation Product Monographs: Proposed Approach for Performance Tests using Non-standard Apparatus (posted 28–Aug–2020; comment deadline 30–Nov–2020; updated 25–Jun–2021)
- New Process and New Revision Markup for Chemical Information Updates in USP–NF (posted 25–Mar–2022)
- Official Date Change for Enoxaparin Sodium Monograph Revision (posted 30-Sep-2022)
- Organic Impurities Procedures: Format Change for Presenting Relative Retention Times (posted 29–Oct–2021) | En español
- Pharmacopeial Forum 48(5) Stimuli Article: Selecting an Appropriate Volume for Subvisible Particles Per Container Calculation (posted 30-Sep-2022)
- Revision Bulletin Notice Posting Update (posted 26–Mar–2021) | En español
- Update: Guidance on the Use of Recombinant Reagents for Bacterial Endotoxin Test (posted 28–Aug–2020)
- Update: Reporting Thresholds in USP–NF Monographs (posted 12–Oct–2020)
- USP General Notices Biologics Nomenclature (posted 09-Jun-2022)
- USP Virtual Roundtable on Reporting Thresholds in Monographs (held on June 29, 2021) (posted 27–Aug–2021)
- USP is announcing a proposal to modify General Chapter <660> and the packaging and storage requirements in specified monographs (posted 27-Jan-2023)
Publication Announcements
- Changes to USP's Description and Solubility Reference Table (posted 30-Sep-2022)
- Chemical Information Updates (posted 16-Dec-2022)
- Correction to Official Date of Posted IRA for Enoxaparin Sodium Monograph (posted 23-Nov-2022)
- Documentary Standard Updated for Equation Uniformity (posted 16-Dec-2022)
- Monographs Affected by Revision to <126> Somatropin Bioidentity Tests (posted 30-Sep-2022)
- Monographs Affected by Revision to <211> Arsenic (posted 29-Apr-2022)
- Monographs Affected by Revision to <251> Lead (posted 29-Apr-2022)
- Monographs Affected by Revision to <261> Mercury (posted 29-Apr-2022)
- Monographs Affected by Revision to <206> Aluminum (posted 29-Apr-2022)
- Monographs Affected by Revision to <241> Iron (posted 29-Apr-2022)
- Monographs Affected by Revision to <291> Selenium (posted 29-Apr-2022)
- Monographs Affected by Revision to <795> Pharmaceutical Compounding- Nonsterile Preparations (posted 01-Nov-2022)
- Monographs Affected by Revision to <797> Pharmaceutical Compounding- Sterile Preparations
- Monographs Affected by Revision to <941> Characterization of Crystalline and Partially Crystalline Solids by X-Ray Powder Diffraction (XRPD) (posted 06–Apr–2021)
- Monographs Affected by a Style Update to the Uniformity of Dosage Units <905> Section (posted 16-Dec-2022)
- Revised General Chapter <795> Published in USP-NF (posted 01-Nov-2022)
- Revised General Chapter <797> Published in USP-NF (posted 01-Nov-2022)
- Upcoming Changes to USP's Description and Relative Solubility Reference Table (posted 24-Jun-2022)
- USP–NF Online: Official Dates for Monographs in Redesigned Format (posted 29-Apr-2022)